179 related articles for article (PubMed ID: 35315504)
1. Epithelial cell adhesion molecule‑targeting designed ankyrin repeat protein‑toxin fusion Ec1‑LoPE exhibits potent cytotoxic action in prostate cancer cells.
Xu T; Liu Y; Schulga A; Konovalova E; Deyev SM; Tolmachev V; Vorobyeva A
Oncol Rep; 2022 May; 47(5):. PubMed ID: 35315504
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model.
Xu T; Schulga A; Konovalova E; Rinne SS; Zhang H; Vorontsova O; Orlova A; Deyev SM; Tolmachev V; Vorobyeva A
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769161
[TBL] [Abstract][Full Text] [Related]
3. Assessing the use of tumor-specific DARPin-toxin fusion proteins for ex vivo purging of cancer metastases from human ovarian cortex before autotransplantation.
Eijkenboom L; Palacio-Castañeda V; Groenman F; Braat D; Beerendonk C; Brock R; Verdurmen W; Peek R
F S Sci; 2021 Nov; 2(4):330-344. PubMed ID: 35559858
[TBL] [Abstract][Full Text] [Related]
4. Effect of a radiolabel biochemical nature on tumor-targeting properties of EpCAM-binding engineered scaffold protein DARPin Ec1.
Deyev SM; Vorobyeva A; Schulga A; Abouzayed A; Günther T; Garousi J; Konovalova E; Ding H; Gräslund T; Orlova A; Tolmachev V
Int J Biol Macromol; 2020 Feb; 145():216-225. PubMed ID: 31863835
[TBL] [Abstract][Full Text] [Related]
5. DARPin Ec1-LMWP protein scaffold in targeted delivery of siRNA molecules through EpCAM cancer stem cell marker.
Babaee N; Talebkhan Garoosi Y; Karimipoor M; Davami F; Bayat E; Safarpour H; Mahboudi F; Barkhordari F
Mol Biol Rep; 2020 Oct; 47(10):7323-7331. PubMed ID: 32979162
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Imaging EpCAM Expression in Ovarian Cancer Using Radiolabeled DARPin Ec1.
Vorobyeva A; Konovalova E; Xu T; Schulga A; Altai M; Garousi J; Rinne SS; Orlova A; Tolmachev V; Deyev S
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32392820
[TBL] [Abstract][Full Text] [Related]
7. Imaging-Guided Therapy Simultaneously Targeting HER2 and EpCAM with Trastuzumab and EpCAM-Directed Toxin Provides Additive Effect in Ovarian Cancer Model.
Xu T; Vorobyeva A; Schulga A; Konovalova E; Vorontsova O; Ding H; Gräslund T; Tashireva LA; Orlova A; Tolmachev V; Deyev SM
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439094
[TBL] [Abstract][Full Text] [Related]
8. Gene delivery to breast cancer by incorporated EpCAM targeted DARPins into AAV2.
Lv YF; Zhang H; Cui Z; Ma CJ; Li YL; Lu H; Wu HY; Yang JL; Cao CY; Sun WZ; Huang XF
BMC Cancer; 2023 Dec; 23(1):1220. PubMed ID: 38082377
[TBL] [Abstract][Full Text] [Related]
9. Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.
Vorobyeva A; Bezverkhniaia E; Konovalova E; Schulga A; Garousi J; Vorontsova O; Abouzayed A; Orlova A; Deyev S; Tolmachev V
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066684
[TBL] [Abstract][Full Text] [Related]
10. Targeted EpCAM-binding for the development of potent and effective anticancer proteins.
Liu Z; Zhang C; Cui B; Wang Y; Lim K; Li K; Thiery JP; Chen J; Ho CL
Biomed Pharmacother; 2023 May; 161():114443. PubMed ID: 36863098
[TBL] [Abstract][Full Text] [Related]
11. EpCAM-Binding DARPins for Targeted Photodynamic Therapy of Ovarian Cancer.
van den Brand D; van Lith SAM; de Jong JM; Gorris MAJ; Palacio-Castañeda V; Couwenbergh ST; Goldman MRG; Ebisch I; Massuger LF; Leenders WPJ; Brock R; Verdurmen WPR
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630661
[TBL] [Abstract][Full Text] [Related]
12. Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1.
Deyev SM; Xu T; Liu Y; Schulga A; Konovalova E; Garousi J; Rinne SS; Larkina M; Ding H; Gräslund T; Orlova A; Tolmachev V; Vorobyeva A
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298801
[TBL] [Abstract][Full Text] [Related]
13. Enzymatic Construction of DARPin-Based Targeted Delivery Systems Using Protein Farnesyltransferase and a Capture and Release Strategy.
Zhang Y; Wang Y; Uslu S; Venkatachalapathy S; Rashidian M; Schaefer JV; Plückthun A; Distefano MD
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232839
[TBL] [Abstract][Full Text] [Related]
14. DARPins recognizing the tumor-associated antigen EpCAM selected by phage and ribosome display and engineered for multivalency.
Stefan N; Martin-Killias P; Wyss-Stoeckle S; Honegger A; Zangemeister-Wittke U; Plückthun A
J Mol Biol; 2011 Nov; 413(4):826-43. PubMed ID: 21963989
[TBL] [Abstract][Full Text] [Related]
15. EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205.
Massoner P; Thomm T; Mack B; Untergasser G; Martowicz A; Bobowski K; Klocker H; Gires O; Puhr M
Br J Cancer; 2014 Aug; 111(5):955-64. PubMed ID: 24992580
[TBL] [Abstract][Full Text] [Related]
16. EpCAM-targeted delivery of nanocomplexed siRNA to tumor cells with designed ankyrin repeat proteins.
Winkler J; Martin-Killias P; Plückthun A; Zangemeister-Wittke U
Mol Cancer Ther; 2009 Sep; 8(9):2674-83. PubMed ID: 19723880
[TBL] [Abstract][Full Text] [Related]
17. Designed Ankyrin Repeat Proteins: A New Class of Viral Entry Inhibitors.
Walser M; Mayor J; Rothenberger S
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298797
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of EpCAM-binding designed ankyrin repeat proteins (DARPins) as targeting moieties for bimodal near-infrared fluorescence and photoacoustic imaging of cancer.
Houvast RD; Badr N; March T; de Muynck LDAN; Sier VQ; Schomann T; Bhairosingh S; Baart VM; Peeters JAHM; van Westen GJP; Plückthun A; Burggraaf J; Kuppen PJK; Vahrmeijer AL; Sier CFM
Eur J Nucl Med Mol Imaging; 2023 Aug; ():. PubMed ID: 37642704
[TBL] [Abstract][Full Text] [Related]
19. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
20. Targeted delivery and endosomal cellular uptake of DARPin-siRNA bioconjugates: Influence of linker stability on gene silencing.
Lorenzer C; Streußnig S; Tot E; Winkler AM; Merten H; Brandl F; Sayers EJ; Watson P; Jones AT; Zangemeister-Wittke U; Plückthun A; Winkler J
Eur J Pharm Biopharm; 2019 Aug; 141():37-50. PubMed ID: 31103742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
